Evidence map›Paper›PMID 30682540›Full record

ArticleNeurobiology of disease2019

TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.

Peter T Nelson, Zsombor Gal, Wang-Xia Wang, Dana M Niedowicz, Sergey C Artiushin, Samuel Wycoff, Angela Wei, Gregory A Jicha, David W Fardo

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Distinct single-nucleus RNA-seq changes among non-neuronal cells in ADNC, LATE-NC, and mixed pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Peter T NelsonDepartment of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA. Electronic address: pnels2@email.uky.edu.
Zsombor GalDepartment of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, USA.
Wang-Xia WangDepartment of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Dana M NiedowiczDepartment of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, USA.
Sergey C ArtiushinDepartment of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, USA.
Samuel WycoffDepartment of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, USA.
Angela WeiSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Gregory A JichaDepartment of Neurology, University of Kentucky, Lexington, KY, USA.
David W FardoSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA; Department of Biostatistics, University of Kentucky, Lexington, KY, USA.
University of Kentucky · US

Funding

University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS)R01AG061111 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2019 to 2025
$3.6M
Novel pathogenetic mechanism for hippocampal sclerosis, a common Alzheimers mimicR01AG057187 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2017 to 2021
$2.2M
Pleiotropy GWAS of Alzheimer's DiseaseR01AG054060 · NIA · UNIVERSITY OF PENNSYLVANIA · PI NAJ, ADAM CHRISTIAN · 2016 to 2020
$2.1M
Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer diseaseR01AG042419 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2013 to 2016
$1.6M
CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL ADR01AG042475 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2013 to 2017
$1.5M
Genomic Architecture of a Key Alzheimer's Disease Mimic: CARTSR56AG057191 · NIA · UNIVERSITY OF KENTUCKY · PI FARDO, DAVID WILLIAM · 2019 to 2020
$1.1M
Testing a therapeutic strategy for hippocampal sclerosis of aging, a key AD mimicR21AG050146 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2016 to 2017
$414k
Aperio ScanScope XT Digital Slide Scanner SystemS10RR026489 · NCRR · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2011 to 2011
$284k
NCRR NIH HHS S10 RR026489NIA NIH HHS P30 AG028383NIA NIH HHS R01 AG042419NIA NIH HHS R01 AG042475NIA NIH HHS R01 AG054060NIA NIH HHS R01 AG057187NIA NIH HHS R01 AG061111NIA NIH HHS R21 AG050146NIA NIH HHS R56 AG057191
6 · The paper itself

Abstract

TDP-43 proteinopathy is very prevalent among the elderly (affecting at least 25% of individuals over 85 years of age) and is associated with substantial cognitive impairment. Risk factors implicated in age-related TDP-43 proteinopathy include commonly inherited gene variants, comorbid Alzheimer's disease pathology, and thyroid hormone dysfunction. To test parameters that are associated with aging-related TDP-43 pathology, we performed exploratory analyses of pathologic, genetic, and biochemical data derived from research volunteers in the University of Kentucky Alzheimer's Disease Center autopsy cohort (n = 136 subjects). Digital pathologic methods were used to discriminate and quantify both neuritic and intracytoplasmic TDP-43 pathology in the hippocampal formation. Overall, 46.4% of the cases were positive for TDP-43 intracellular inclusions, which is consistent with results in other prior community-based cohorts. The pathologies were correlated with hippocampal sclerosis of aging (HS-Aging) linked genotypes. We also assayed brain parenchymal thyroid hormone (triiodothyronine [T3] and thyroxine [T4]) levels. In cases with SLCO1A2/IAPP or ABCC9 risk associated genotypes, the T3/T4 ratio tended to be reduced (p = .051 using 2-tailed statistical test), and in cases with low T3/T4 ratios (bottom quintile), there was a higher likelihood of HS-Aging pathology (p = .025 using 2-tailed statistical test). This is intriguing because the SLCO1A2/IAPP and ABCC9 risk associated genotypes have been associated with altered expression of the astrocytic thyroid hormone receptor (protein product of the nearby gene SLCO1C1). These data indicate that dysregulation of thyroid hormone signaling may play a role in age-related TDP-43 proteinopathy.

Indexed as

ThyroxineTriiodothyronineAgedAged, 80 and overAgingBrainFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedOrganic Anion TransportersPolymorphism, Single NucleotideRisk FactorsSulfonylurea ReceptorsTDP-43 ProteinopathiesABCC9 protein, humanOrganic Anion TransportersSLCO1A2 protein, humanSulfonylurea ReceptorsThyroxineTriiodothyronineDementiaGRNNeuropathologyScanScopeSLCO1A2SNPTMEM106B

Identifiers

PMID30682540
PMCPMC6696921
OpenAlexW2913527829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.